Evidence map›Paper›PMID 41356724›Full record

ReviewRSC advances2025

Recent advances in hydrogel-based therapeutics for lung cancer.

Ke Sun, Jiaoyan Qiu, Yawen Wang, Fengyi Han, Huaxin Song, Tong Wu, Yuanfei Wang, Wenjie Jiao

Abstract readReview
In one paragraph

Review in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ke SunDepartment of Thoracic Surgery, The Affiliated Hospital of Qingdao University, Qingdao Medical College, Qingdao University Qingdao 266000 China jiaowj@qduhospital.cn.
Jiaoyan QiuMedical Research Center, The Affiliated Hospital of Qingdao University, Qingdao Medical College, Qingdao University Qingdao 266000 China.
Yawen WangSchool of Rehabilitation Sciences and Engineering, University of Health and Rehabilitation Sciences Qingdao 266113 China.
Fengyi HanDepartment of Thoracic Surgery, The Affiliated Hospital of Qingdao University, Qingdao Medical College, Qingdao University Qingdao 266000 China jiaowj@qduhospital.cn.
Huaxin SongDepartment of Thoracic Surgery, The Affiliated Hospital of Qingdao University, Qingdao Medical College, Qingdao University Qingdao 266000 China jiaowj@qduhospital.cn.
Tong WuMedical Research Center, The Affiliated Hospital of Qingdao University, Qingdao Medical College, Qingdao University Qingdao 266000 China.ORCID https://orcid.org/0000-0001-8822-1868
Yuanfei WangQingdao Stomatological Hospital Affiliated to Qingdao University Qingdao 266001 China zhizunbao19@163.com.ORCID https://orcid.org/0000-0003-4134-307X
Wenjie JiaoDepartment of Thoracic Surgery, The Affiliated Hospital of Qingdao University, Qingdao Medical College, Qingdao University Qingdao 266000 China jiaowj@qduhospital.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer is one of the most commonly diagnosed types of cancer worldwide, attracting significant attention from researchers due to its high mortality rate and limited treatment options. The complex biological mechanisms associated with lung cancer pose substantial challenges for effective treatment. In recent years, hydrogels have emerged as a promising therapeutic material, garnering considerable interest due to their excellent biocompatibility and biodegradability. These hydrogels can mimic the extracellular matrix of the alveolar microenvironment and have the capability to reduce inflammation while promoting the repair and regeneration of lung tissue. This dual functionality may help mitigate the progression of lung cancer. In this review, we summarize the latest advances and applications of various types of hydrogels in the treatment of lung cancer. We begin by providing an overview of the fabrication methods and characteristics of different hydrogels designed explicitly for lung cancer therapy. Next, we systematically explore their emerging applications in clinical interventions, focusing on their roles in enhancing the therapeutic effectiveness of chemoradiotherapy drugs. Finally, we discuss the current limitations of these hydrogel-based systems and suggest potential directions for future research in this evolving field.

Identifiers

PMID41356724
PMCPMC12679397

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.